Triangle Securities Wealth Management boosted its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 62.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,746 shares of the conglomerate's stock after buying an additional 1,440 shares during the period. Triangle Securities Wealth Management's holdings in Danaher were worth $860,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of DHR. Decker Retirement Planning Inc. acquired a new position in Danaher during the fourth quarter valued at $31,000. Teachers Insurance & Annuity Association of America acquired a new position in shares of Danaher in the 3rd quarter valued at about $39,000. MidAtlantic Capital Management Inc. purchased a new stake in shares of Danaher in the third quarter worth approximately $40,000. FSA Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter worth approximately $50,000. Finally, Darwin Wealth Management LLC purchased a new position in Danaher during the third quarter valued at approximately $55,000. 79.05% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on DHR shares. Scotiabank initiated coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a "sector perform" rating and a $265.00 target price for the company. Stifel Nicolaus lifted their price objective on Danaher from $250.00 to $265.00 and gave the company a "hold" rating in a research report on Wednesday, October 23rd. UBS Group lowered their target price on Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a research note on Wednesday, October 23rd. Citigroup reduced their price target on Danaher from $305.00 to $285.00 and set a "buy" rating for the company in a report on Monday, January 6th. Finally, Raymond James lowered their price target on Danaher from $310.00 to $300.00 and set an "outperform" rating for the company in a research note on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $286.80.
Check Out Our Latest Analysis on DHR
Danaher Stock Performance
Shares of NYSE DHR traded down $3.49 during trading hours on Friday, hitting $238.41. 3,044,734 shares of the company's stock were exchanged, compared to its average volume of 2,640,177. The stock has a market capitalization of $172.20 billion, a price-to-earnings ratio of 45.50, a PEG ratio of 4.23 and a beta of 0.83. The company's 50-day moving average price is $234.85 and its 200-day moving average price is $253.42. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a 1-year low of $222.53 and a 1-year high of $281.70.
Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. During the same period in the prior year, the business earned $2.02 earnings per share. Danaher's revenue for the quarter was up 3.1% compared to the same quarter last year. On average, sell-side analysts expect that Danaher Co. will post 7.49 earnings per share for the current fiscal year.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher's payout ratio is 20.61%.
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.